作者: A K Das , J W Aquilina , A K Hajra
DOI: 10.1016/S0021-9258(18)32834-5
关键词: Chemistry 、 Stimulation 、 Internal medicine 、 Protein biosynthesis 、 Cycloheximide 、 Bezafibrate 、 Microsome 、 Endocrinology 、 Gemfibrozil 、 Glycerophosphate Acyltransferase 、 Clofibrate
摘要: Abstract Administration of clofibrate to adult mice (20-25 mg clofibrate/day) increased liver glycerophosphate acyltransferase (EC 2.3.1.15) activity by 2.3-fold within 24 h. This was mainly localized in the microsomal fraction. Three other hypolipidemic drugs, i.e. Bezafibrate (Boehringer Mannheim Co.), Gemfibrozil (Warner-Lambert Co.) and Wy-14,643 (Wyeth Laboratories), when fed mice, also 2-3-fold Simultaneous administration inhibitors protein biosynthesis, such as cycloheximide or actinomycin D completely abolished stimulation clofibrate.